Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 22968343)

1.

Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.

Nakamori M, Takahashi T, Yamazaki Y, Kurashige T, Yamawaki T, Matsumoto M.

Neuroreport. 2012 Oct 24;23(15):867-72. doi: 10.1097/WNR.0b013e328358720b.

PMID:
22968343
2.

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.

Acta Neuropathol. 2002 Feb;103(2):91-9. Epub 2001 Nov 29.

PMID:
11810173
3.

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF.

Brain Res. 1998 Jun 29;797(2):267-77.

PMID:
9666145
4.

Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.

Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, Carmona M, Blanco R, Puig B.

Brain Pathol. 2003 Jan;13(1):62-78.

PMID:
12580546
6.
7.

Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.

Nakamori M, Takahashi T, Nishikawa T, Yamazaki Y, Kurashige T, Maruyama H, Arihiro K, Matsumoto M.

PLoS One. 2013 Nov 28;8(11):e80995. doi: 10.1371/journal.pone.0080995. eCollection 2013.

8.

Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.

Yamazaki Y, Takahashi T, Hiji M, Kurashige T, Izumi Y, Yamawaki T, Matsumoto M.

Neurosci Lett. 2010 Jun 21;477(2):86-90. doi: 10.1016/j.neulet.2010.04.038. Epub 2010 Apr 24.

PMID:
20420883
9.
10.

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

Jämsä A, Hasslund K, Cowburn RF, Bäckström A, Vasänge M.

Biochem Biophys Res Commun. 2004 Jul 2;319(3):993-1000.

PMID:
15184080
11.

Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Shukla V, Skuntz S, Pant HC.

Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7. Review.

12.

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.

Wang JZ, Grundke-Iqbal I, Iqbal K.

Eur J Neurosci. 2007 Jan;25(1):59-68.

13.

Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus.

Holzer M, Gärtner U, Stöbe A, Härtig W, Gruschka H, Brückner MK, Arendt T.

Acta Neuropathol. 2002 Nov;104(5):471-81. Epub 2002 Jul 3.

PMID:
12410395
14.

Pathological tau tangles localize to focal cortical dysplasia in older patients.

Sen A, Thom M, Martinian L, Harding B, Cross JH, Nikolic M, Sisodiya SM.

Epilepsia. 2007 Aug;48(8):1447-54. Epub 2007 Apr 18.

PMID:
17441989
15.

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.

Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA.

J Neurochem. 2001 Jan;76(2):435-41.

PMID:
11208906
16.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
17.

Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions.

Kannanayakal TJ, Tao H, Vandre DD, Kuret J.

Acta Neuropathol. 2006 May;111(5):413-21. Epub 2006 Mar 24.

PMID:
16557393
18.

Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.

Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S, Haraguchi T, Kawai K, Kuroda S.

Neuroreport. 2000 Aug 3;11(11):2473-7.

PMID:
10943706
19.

Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.

Chalmers KA, Love S.

J Neuropathol Exp Neurol. 2007 Feb;66(2):158-67.

PMID:
17279001
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk